PT  - JOURNAL ARTICLE
AU  - Avila-Ponce de León, Ugo
AU  - Pérez, Ángel G. C.
AU  - Avila-Vales, Eric
TI  - An SEIARD epidemic model for COVID-19 in Mexico: mathematical analysis and state-level forecast
AID  - 10.1101/2020.05.11.20098517
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.11.20098517
4099  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098517.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098517.full
AB  - We propose an SEIARD mathematical model to investigate the current outbreak of coronavirus disease (COVID-19) in Mexico. Our model incorporates the asymptomatic infected individuals, who represent the majority of the infected population (with symptoms or not) and could play an important role in spreading the virus without any knowledge. We calculate the basic reproduction number (R0) via the next-generation matrix method and estimate the per day infection, death and recovery rates. The local stability of the disease free equilibrium is established in terms of R0. A sensibility analysis is performed to determine the relative importance of the model parameters to the disease transmission. We calibrate the parameters of the SEIARD model to the reported number of infected cases and fatalities for several states in Mexico by minimizing the sum of squared errors and attempt to forecast the evolution of the outbreak until August 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUgo Avila-Ponce de León received a fellowship (CVU: 774988) from Consejo Nacional de Ciencia y Tecnología (CONACYT). This article was supported in part by Mexican Sistema Nacional de Investigadores under CVU 15284.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available at https://github.com/UgoAvila/COVID-19.Mexico https://github.com/UgoAvila/COVID-19.Mexico